Pinnacle Financial Partners (Tennessee)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$32.5M Buy
42,638
+1,902
+5% +$1.42M 0.78% 28
2025
Q2
$31.8M Buy
40,736
+1,538
+4% +$1.2M 0.67% 29
2025
Q1
$32.4M Buy
39,198
+3,916
+11% +$3.26M 0.65% 30
2024
Q4
$27.2M Sell
35,282
-679
-2% -$562K 0.55% 39
2024
Q3
$31.9M Buy
35,961
+275
+0.8% +$247K 0.64% 31
2024
Q2
$32.3M Sell
35,686
-5,474
-13% -$4.38M 0.69% 27
2024
Q1
$32M Buy
41,160
+3,620
+10% +$2.58M 0.69% 28
2023
Q4
$21.9M Sell
37,540
-723
-2% -$422K 0.52% 48
2023
Q3
$20.6M Sell
38,263
-2,988
-7% -$1.54M 0.53% 51
2023
Q2
$19.3M Sell
41,251
-3,872
-9% -$1.62M 0.49% 56
2023
Q1
$15.5M Buy
45,123
+204
+0.5% +$68.8K 0.42% 65
2022
Q4
$16.4M Buy
44,919
+23
+0.1% +$8.15K 0.47% 62
2022
Q3
$14.5M Sell
44,896
-212
-0.5% -$67.2K 0.53% 57
2022
Q2
$14.6M Buy
45,108
+1,262
+3% +$379K 0.52% 56
2022
Q1
$12.6M Sell
43,846
-3,627
-8% -$933K 0.4% 75
2021
Q4
$13.1M Buy
47,473
+314
+0.7% +$79.6K 0.41% 74
2021
Q3
$10.9M Buy
47,159
+283
+0.6% +$69.8K 0.38% 82
2021
Q2
$10.8M Sell
46,876
-459
-1% -$92.2K 0.44% 75
2021
Q1
$8.84M Sell
47,335
-24,309
-34% -$4.76M 0.4% 82
2020
Q4
$12.1M Sell
71,644
-2,024
-3% -$302K 0.6% 45
2020
Q3
$10.9M Buy
73,668
+1,707
+2% +$264K 0.59% 48
2020
Q2
$11.8M Buy
71,961
+2,809
+4% +$431K 0.67% 41
2020
Q1
$9.59M Buy
69,152
+11,374
+20% +$1.56M 0.66% 36
2019
Q4
$7.59M Buy
57,778
+138
+0.2% +$16K 0.47% 64
2019
Q3
$6.45M Buy
57,640
+6,004
+12% +$668K 0.46% 67
2019
Q2
$5.72M Buy
51,636
+3,018
+6% +$355K 0.43% 72
2019
Q1
$6.31M Buy
48,618
+2,239
+5% +$272K 0.51% 59
2018
Q4
$5.37M Buy
46,379
+903
+2% +$101K 0.51% 57
2018
Q3
$4.88M Buy
45,476
+566
+1% +$56.6K 0.41% 72
2018
Q2
$3.83M Buy
44,910
+2,566
+6% +$211K 0.36% 82
2018
Q1
$3.28M Buy
42,344
+500
+1% +$40.3K 0.33% 89
2017
Q4
$3.53M Buy
41,844
+4,761
+13% +$405K 0.37% 78
2017
Q3
$3.17M Buy
37,083
+55
+0.1% +$4.51K 0.41% 73
2017
Q2
$3.05M Buy
37,028
+2,076
+6% +$169K 0.43% 74
2017
Q1
$2.94M Buy
34,952
+3,378
+11% +$271K 0.58% 57
2016
Q4
$2.32M Buy
31,574
+6,170
+24% +$459K 0.5% 64
2016
Q3
$2.04M Sell
25,404
-573
-2% -$45.9K 0.46% 66
2016
Q2
$2.08M Sell
25,977
-20,978
-45% -$1.58M 0.48% 66
2016
Q1
$3.38M Buy
46,955
+12,139
+35% +$919K 0.87% 38
2015
Q4
$2.93M Sell
34,816
-6,169
-15% -$512K 0.91% 29
2015
Q3
$3.43M Sell
40,985
-919
-2% -$77.6K 1.08% 26
2015
Q2
$3.5M Buy
41,904
+352
+0.8% +$26.8K 1.11% 23
2015
Q1
$3.02M Buy
41,552
+4,649
+13% +$331K 1.01% 35
2014
Q4
$2.55M Buy
36,903
+1,106
+3% +$74.7K 0.89% 41
2014
Q3
$2.32M Buy
35,797
+648
+2% +$41K 0.89% 40
2014
Q2
$2.19M Buy
35,149
+15,533
+79% +$927K 0.87% 44
2014
Q1
$1.16M Buy
+19,616
New +$1.09M 0.52% 62

Other funds holding LLY

Pinnacle Financial Partners (Tennessee)'s LLY Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its Eli Lilly (LLY) stake by 4.7% in Q3 2025, buying an estimated $1.42M and bringing the position to 42,638 shares worth $32.5M. The position accounts for 0.78% of the portfolio, ranked #28.

Pinnacle Financial Partners (Tennessee) first reported a position in LLY in Q1 2014 and has held it in 47 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 42,638 shares of Eli Lilly worth $32.5M as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) bought 1,902 Eli Lilly shares in Q3 2025, an estimated $1.42M.
  • Eli Lilly made up 0.78% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #28 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Eli Lilly in Q1 2014 and has held it in 47 quarters since.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.